Antilymphocyte antibodies and systemic lupus erythematosus.
Antilymphocyte antibodies and systemic lupus erythematosus.
复制标题
抗淋巴细胞抗体和系统性红斑狼疮。
DOI:
10.1002/art.1780300215
复制
发表时间:
1987
影响因子:
--
通讯作者:
Schlossman,SF
中科院分区:
文献类型:
--
作者:
Morimoto,C;Schlossman,SF
Systemic lupus erythematosus (SLE), considered the quintessential autoimmune disease, is characterized by the spontaneous production of multiple autoantibodies, including antibodies reactive with lymphocytes (1). Since patients with SLE manifest lymphopenia (2) and impaired T cell function (3, 4), a relationship between the antilymphocyte antibodies and the impaired T cell function has long been sought. Defective T suppressor cell function has been reported in many patients with SLE (5-7). Moreover, an attempt has been made to associate the dysfunction of T suppressor cells with the specific reactivities of antilymphocyte antibodies (8-10). In addition to suppressor cell dysfunction, a defect in inducer cell function may be present in SLE patients, concomitant with, or independent of, suppressor cell abnormalities (1 1). Since inducer cells are necessary for induction of a variety of cellular functions (12, 13), a defect in these cells could underlie defects in B cell antibody production, T cell-mediated effector functions, and/or suppressor cell functions. This latter point is illustrated by the defect in the autologous mixed lymphocyte reaction (AMLR) in patients with SLE (14). Although this defect has been associated with a defect in suppressor cell function, it is now clear that both the AMLR and the suppressor